Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.

A major challenge in self-powered wearable sensors for health care monitoring is distinguishing different signals when they occur at the same time. Researchers addressed this issue by uncovering a new ...

RLF-TD011 has previously received orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for the treatment of EB. The Company also intends to seek qualified infectious disease ...

HMP Global, in collaboration with the Alliance of Wound Care Stakeholders, has unveiled a new webinar series aimed at ...

Why We Love It: Accepted by the National Rosacea Society, this cleansing oil is clinically proven to reduce redness as it ...

Integrating the nanoflowers into a wound dressing helps to fight harmful bacteria while keeping healthy human cells intact.

The South Carolina Burn Center at the Medical University of South Carolina and The Zucker Institute for Innovation ...

Skin substitute grafts made from cellular and tissue-based products have helped to revolutionize chronic wound care, but federal regulators are greatly reducing coverage for Medicare beneficiaries.

As home health providers increasingly serve people with more complicated and serious conditions, and the push for ...